Scancell Holdings plc (AIM:SCLP)
London · Delayed Price · Currency is GBP · Price in GBX 23.45
+1.45 (6.59%)
May 26, 2026, 4:22 PM GMT
Scancell Holdings Market Cap
Scancell Holdings has a market cap or net worth of 238.69 million as of May 26, 2026. Its market cap has increased by 144.59% in one year.
Market Cap
238.69M
Enterprise Value
246.30M
Revenue
4.71M
Ranking
n/a
PE Ratio
n/a
Stock Price
23.45
Market Cap Chart
Since June 29, 2009, Scancell Holdings's market cap has increased from 3.13M to 238.69M, an increase of 7,516.03%. That is a compound annual growth rate of 29.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 228.31M | 122.22% |
| Dec 31, 2025 | 102.74M | -6.96% |
| Dec 31, 2024 | 110.43M | 28.31% |
| Dec 29, 2023 | 86.06M | -57.34% |
| Dec 30, 2022 | 201.77M | 23.75% |
| Dec 31, 2021 | 163.04M | 42.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oxford Nanopore Technologies | 1.26B |
| Oxford Biomedica | 747.29M |
| Avacta Group | 358.09M |
| PureTech Health | 334.94M |
| Bioventix | 87.52M |
| Faron Pharmaceuticals Oy | 82.80M |
| Ondine Biomedical | 77.93M |
| 4basebio | 75.07M |